Ophthotech Announces FovistaÂ® Phase 2b Independent Analysis Shows that FovistaÂ® Anti-PDGF Therapy, Combined with Anti-VEGF Therapy, is Associated with a Reduction of Sub-retinal Fibrosis in Wet AMD Patients